DrugPatentWatch Database Preview
Taro Company Profile
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
TARO has two hundred and fourteen approved drugs.
There are ten US patents protecting TARO drugs. There are three tentative approvals on TARO drugs.
Summary for Taro
| US Patents: | 10 |
| Tradenames: | 111 |
| Ingredients: | 94 |
| NDAs: | 214 |
| Patent Litigation for Taro: | See patent lawsuits for Taro |
| PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm Inds | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078525-004 | Jan 27, 2009 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro | NITROFURAZONE | nitrofurazone | OINTMENT;TOPICAL | 086156-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro | FLUOCINONIDE | fluocinonide | SOLUTION;TOPICAL | 074799-001 | Dec 31, 1996 | AT | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Taro | CLOBETASOL PROPIONATE (EMOLLIENT) | clobetasol propionate | CREAM;TOPICAL | 075633-001 | May 17, 2000 | AB2 | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro | BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | LOTION;TOPICAL | 074272-001 | Sep 30, 1994 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Taro
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 5,881,926 | ➤ Sign Up |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ➤ Sign Up |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 5,881,926 | ➤ Sign Up |
| Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,399,079 | ➤ Sign Up |
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
Premature patent expirations for TARO
International Patents for Taro Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1036009 | ➤ Sign Up |
| Japan | 2003510259 | ➤ Sign Up |
| Israel | 195759 | ➤ Sign Up |
| Japan | 2009500422 | ➤ Sign Up |
| Spain | 2253920 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB97/078 | United Kingdom | ➤ Sign Up | PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522 |
| 2015 00014 | Denmark | ➤ Sign Up | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119 |
| C/GB98/002 | United Kingdom | ➤ Sign Up | PRODUCT NAME: TAZAROTENE : ETHYL 6-(2-(4,4-DIMETHYLTHIOCHROMAN-6-YL) ETHYNYL) NICOTINOATE; REGISTERED: DE 37393.00.00 19961203; DE 37393.01.00 19961203; UK 00426/0097 19970730; UK 00426/0096 19970730 |
| 399030 | Germany | ➤ Sign Up | PRODUCT NAME: ESCITALOPRAMOXALAT; NAT. REGISTRATION NO/DATE: 55880.00.00 55880.01.00 55880.02.00 55880.03.00 55884.00.00 55884.01.00 55884.02.00 55884.03.00 55888.00.00 55888.01.00 55888.02.00 55888.03.00 20030408 FIRST REGISTRATION: SCHWEDEN 17084 17085 17086 17087 20011207 |
| 1999 | Austria | ➤ Sign Up | PRODUCT NAME: FOSPHENYTOIN-NATRIUM; NAT. REGISTRATION NO/DATE: 1-22664 19980728; FIRST REGISTRATION: GB 00019/0157 19980204 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
